NovaBay Pharmaceuticals, Inc. (NBY)’s New Product For Serious Eye Conditions Highlighted In CEOLIVE.TV Interview
7/3/2014 6:09:54 AM
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today that CEOLIVE.TV, an online service that delivers news about companies to investors, has highlighted NovaBay’s important advance in eye care through an interview with Kathryn Najafi-Tagol, M.D., the founder and director of the Eye Institute of Marin in San Rafael, California.
In the interview with Mike Elliott of CEOLIVE.TV, Dr. Najafi-Tagol described the success she’s been having with NovaBay’s new i-LidTM Cleanser:
Help employers find you! Check out all the jobs and post your resume.
comments powered by